AMY PITTS: Open Payments
NPI 1427207570 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 65 payments from 17 companies in 2025. Trend: 2023 $1,715 · 2024 $1,188 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $285 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| Sumitomo Pharma America, Inc. | 7 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $90 |
| Viatris Specialty LLC | 3 | $75 |
| PFIZER INC. | 4 | $69 |
| ABBVIE INC. | 4 | $61 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Corcept Therapeutics | 2 | $37 |
Products named: Rybelsus, Ozempic, GEMTESA, CAPLYTA, Kerendia, FARXIGA, YUPELRI, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
